Know more... - Pancreatic Cancer India

Dr Bhawna Sirohi’s CV
35. Implications of impaired renal function at the time of initiation of infusional
chemotherapy including cyclophosphomide (C-VAMP) in patients with newlydiagnosed
myeloma. 28 th EBMT Annual Meeting, Montreux, Switzerland. 26 th
March 2002.
36. Early high-resolution computed tomography (HRCT) scans allow prompt
diagnosis and efficacious treatment of invasive pulmonary aspergillosis (IPA) in
immunocompromised patients with haematologic malignancies. 28 th EBMT
Annual Meeting, Montreux, Switzerland. 27 th March 2002.
37. Clinical implications and consequences of leukapheresis to reduce tumour burden
in newly-diagnosed patients with hyperleukocytosis (HL) and acute myeloid
leukaemia. 28 th EBMT Annual Meeting, Montreux, Switzerland. 26 th March
2002.
38. Allogeneic transplantation with melphalan-total body irradiation from HLAidentical
siblings for AML in first remission: higher relapse rates with marrowderived
stem cell grafts compared to blood despite similar chronic graft-versushost
disease. 28 th EBMT Annual Meeting, Montreux, Switzerland. 27 th March
2002.
39. Administration of weekly cyclophosphamide as part of infusional induction
chemotherapy (C-VAMP) does not affect subsequent peripheral blood stem cell
collection in patients with myeloma. 28 th EBMT Annual Meeting, Montreux,
Switzerland. 26 th March 2002.
40. 20-year follow-up of allogeneic bone marrow transplantation with
cyclophosphamide - TBI and cyclosporine for acute myeloid leukaemia in first
complete remission. 28 th EBMT Annual Meeting, Montreux, Switzerland. 26 th
March 2002.
41. Does the Number of Infused CD34 Cells Affect the Long-Term Outcome of
Myeloma Patients Treated with High-Dose Melphalan and Auto transplantation?
7 th Congress of EHA, 6-9 th June 2002, Florence, Italy.
42. The Addition of Weekly Cyclosphosphamide to Infusional Induction
Chemotherapy (Vincristine, Doxorubicin, and Methylprednisolone) Does Not
Affect Subsequent Stem Cell Collection in Patients with Myeloma. 7 th Congress
of EHA, 6-9 th June 2002, Florence, Italy.
43. Bone Marrow or Peripheral Blood Stem Cell Auto transplantation for AML in
First Remission? A Matched-Pair Analysis from the Royal Marsden Hospital and
the European Blood and Marrow Transplant Group (EBMT). 7 th Congress of
EHA, 6-9 th June 2002, Florence, Italy.
44. Early high resolution CT (HRCT) scans allow for prompt diagnosis and
efficacious treatment of invasive pulmonary aspergillosis (IPA) in immunocompromised
patients with haematologic malignancies. 7 th Congress of EHA, 6-
9 th June 2002, Florence, Italy.
45. Implications of impaired renal function at the time of initiation of infusional
chemotherapy (C-VAMP) in patients with newly-diagnosed myeloma. 7 th
Congress of EHA, 6-9 th June 2002, Florence, Italy.
46. Clinical implications and consequences of leukapheresis to reduce tumour burden
in newly-diagnosed patients with hyperleukocytosis (HL) and acute myeloid
leukaemia. Annual meeting of British Society of Haematology, Brighton, 2002,
47. Outcome of auto transplantation in 118 adult acute myeloid leukaemia patients in
first complete remission: impact of consolidation chemotherapy (CC). Annual
meeting of British Society of Haematology, Brighton, 2002,
16